1. Home
  2. RAYA vs INM Comparison

RAYA vs INM Comparison

Compare RAYA & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

N/A

Current Price

$4.04

Market Cap

4.2M

ML Signal

N/A

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.22

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
INM
Founded
2019
1981
Country
China
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.7M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
RAYA
INM
Price
$4.04
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
145.5K
Earning Date
04-17-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,101,325.00
$4,798,116.00
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.78
N/A
52 Week Low
$3.13
$1.13
52 Week High
$736.99
$8.27

Technical Indicators

Market Signals
Indicator
RAYA
INM
Relative Strength Index (RSI) 46.80 40.93
Support Level $4.20 $1.18
Resistance Level $4.50 $1.35
Average True Range (ATR) 0.47 0.10
MACD -0.04 0.01
Stochastic Oscillator 17.77 17.19

Price Performance

Historical Comparison
RAYA
INM

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: